Drug intelligence / Profile preview

Salicylamide

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Salicylamide is a non-prescription small molecule drug, an amide derivative of salicylic acid, known for its analgesic and antipyretic properties. It has been historically used to alleviate mild to moderate pain and reduce fever, often in combination with other analgesics like aspirin and caffeine. Its primary mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2, thereby reducing the production of prostaglandins responsible for inflammation, pain, and fever. While its efficacy as a single agent for pain and fever has been debated compared to aspirin and acetaminophen, it is still used in various combination preparations. Beyond its traditional uses, salicylamide and its derivatives are being investigated for a wide range of therapeutic applications, including as potential anti-HBV agents, PARP-1 inhibitors for cancer therapy, and for treating Alzheimer's disease through cholinesterase inhibition and anti-aggregation effects. It also exhibits antibacterial activity, including against multidrug-resistant *Neisseria gonorrhoeae*, and can induce melanin synthesis.

Brand names
ExaprinMedi-First Pain ReliefNo PainPainAid
Other names
o-hydroxybenzamideamide of salicyl2-hydroxybenzamide
02

Targets

COXAHR (Aryl hydrocarbon receptor)

Beyond the preview

Go deeper on Salicylamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salicylamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call